참고문헌
- HE J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am 1997;81:1077-97 https://doi.org/10.1016/S0025-7125(05)70568-X
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23 https://doi.org/10.1016/S0140-6736(05)70151-3
- Skaric-Juric T. Path analysis of familial resemblance in blood pressure in Middle Dalmatia, Croatia. Coll Anthropol 2003;27: 229-37
- Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 2006;7:3-14 https://doi.org/10.3317/jraas.2006.003
- Barbalic M, Skaric-Juric T, Cambien F, et al. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens 2006;19:837-42 https://doi.org/10.1016/j.amjhyper.2006.01.004
- Tiret L, Blanc H, Ruidavets JB, et al. Gene polymorphism of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke. J Hypertens 1998; 16:37-44 https://doi.org/10.1097/00004872-199816010-00007
- Dzida G, Sobstyl J, Puzniak A, Golon P, Mosiewicz J, Hanzlik J. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 gene in essential hypertension in a Polish population. Med Sci Monit 2001;7:1236-41
- Curnow KM, Pascoe L, White PC. Genetic analysis of the human type-1 angiotensin receptor. Mol Endocrinol 1992;6:1113-8 https://doi.org/10.1210/me.6.7.1113
- Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type I receptor (AT1R) locus and myocardial infarction. Clin Genet 1997;52:71-6 https://doi.org/10.1111/j.1399-0004.1997.tb02521.x
- Alvarez R, Reguero JR, Batella A, et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998;40:375-9 https://doi.org/10.1016/S0008-6363(98)00179-5
- Hong YM, Lee JY, Jung JW, et al. Normal blood pressure values and percentile curves in children. Korean Circ J 2006;36:744-52 https://doi.org/10.4070/kcj.2006.36.11.744
-
Jung JH, Min PK, Park HY, et al. The effect of
$\beta$ 2-adrenergic receptor gene polymorphism on the risk of essential hypertension. Korean Circ J 2005;35:753-58 https://doi.org/10.4070/kcj.2005.35.10.753 - Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 2006;7:3-14 https://doi.org/10.3317/jraas.2006.003
- Burnier M, Brunner HR. Angiotensin II receptor antagonist. Lancet 2000;355:637-45 https://doi.org/10.1016/S0140-6736(99)10365-9
- Weir MR. Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far. J Clin Hypertens 2006;8: 99-105 https://doi.org/10.1111/j.1524-6175.2005.04648.x
- Stankovic A, Zivkovic M, Glisic S, Alavantic D. Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population. Clin Chim Acta 2003;327:181-5 https://doi.org/10.1016/S0009-8981(02)00340-6
- Zhu S, Meng QH. Association of angiotensin II type 1 receptor gene polymorphism with carotid atherosclerosis. Clin Chem Lab Med 2006;44:282-4 https://doi.org/10.1515/CCLM.2006.048
- Rehman A, Rasool AH, Naing L, Roshan TM, Rahman AR. Influence of the angiotensin II type 1 receptor gene 1166A>C polymorphism on BP and aortic pulse wave velocity among Malays. Ann Hum Genet 2007;71:86-95 https://doi.org/10.1111/j.1469-1809.2006.00304.x
- Miyama N, Hasegawa Y, Suzuki M, et al. Investigation of major genetic polymorphisms in the renin-angiotensin-aldosterone system in subjects with young-onset hypertension selected by a targeted- screening system at university. Clin Exp Hypertens 2007; 29:61-7 https://doi.org/10.1080/10641960601096968
- Lazzerini PE, Capecchi PL, Selvi E, et al. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev 2007;6:503-9 https://doi.org/10.1016/j.autrev.2007.03.008
- Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146;483-94 https://doi.org/10.1093/oxfordjournals.aje.a009302
- O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22 https://doi.org/10.1056/NEJM199901073400103
- Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B. Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis 2005;179:325-31 https://doi.org/10.1016/j.atherosclerosis.2004.10.015
- Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range. Stroke 2006;37:87-92 https://doi.org/10.1161/01.STR.0000196964.24024.ea
- Hong YM, Koo HS, Lee JY, et al. Serum cytokine levels in hypertensive children. Korean Circ J 2007;37:312-7 https://doi.org/10.4070/kcj.2007.37.7.312
- Sharma M, Rai SK, Tiwari M, Chandra R. Effect of hyperhomo cysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol 2007;574:49-60 https://doi.org/10.1016/j.ejphar.2007.07.022
- Dai J, Wang X. Immunoregulatory effects of homocysteine on cardiovascular diseases. Sheng Li Xue Bao 2007;59:585-92
- Sen U, Herrmann M, Herrmann W, Tyragi SC. Synergism between AT1 receptor and hyperhomocysteine during vascular remodeling. Clin Chem Lab Med 2007;45:1771-6 https://doi.org/10.1515/CCLM.2007.354
- Frankel WN, Schork NJ. Who's afraid of epistasis? Nat Genet 1996;14:371-3 https://doi.org/10.1038/ng1296-371